CPT Capital is the venture arm of a leading private family office and one of the pioneer investors in alternative protein — with arguably unmatched sector expertise. The portfolio of 58 investments includes 4 unicorns (Beyond Meat and Impossible Foods among them), 2 IPOs, and 4 acquisitions. They led ENOUGH's $43.5M Series B (mycoprotein technology) alongside HAL and Scottish Enterprise, demonstra...
Cambridge, United States
Zurich, Switzerland
San Diego, United States
San Francisco, United States
Denver, United States
Menlo Park, United States